RGC
Regencell Bioscience Holdings Ltd
6.80$
+7.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Regencell Bioscience Holdings Ltd (RGC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -2.6 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 14 | Q2 14 | Q3 14 | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128 | 85 | -28 | 164 | 102 | 188 | -73 | 218 | 181 | 58 | 9.1 | 163 | 250 | -42 | 48 | 154 | 0.0 | -0.2 | 0.0 | -0.2 | 0.0 | -0.2 | -0.2 | -0.2 | -161 | -2.6 | – | -2.6 | -5,427 | -2.5 | 0.0 | -2.5 | 1.5 | -2.0 | – | -2.0 | – | – | – | -2.6 | |
| 53 | 52 | 53 | 54 | 54 | 54 | 53 | 56 | 56 | 57 | 59 | 60 | 61 | 63 | 62 | 64 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -189 | 0.3 | – | 0.3 | 416 | 0.4 | – | 0.4 | 0.8 | 0.4 | – | 0.4 | – | – | – | 0.0 | |
| 1.9 | 2.3 | 2.2 | 3.0 | 1.7 | 2.2 | 2.2 | 2.2 | 1.8 | 2.3 | 2.5 | 2.2 | 2.2 | 2.3 | 2.4 | 2.3 | – | – | – | – | – | – | – | – | -7.0 | 1.4 | 0.0 | 1.4 | 2,751 | 0.5 | 0.0 | 0.5 | 0.0 | 0.2 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 1.6 | |
| 18 | -6.9 | -98 | 45 | 12 | 84 | -156 | 95 | 61 | -46 | -100 | 18 | 101 | -148 | -32 | 33 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.3 | 148 | -0.5 | – | -0.5 | 148 | -0.3 | – | -0.3 | – | -0.3 | – | -0.3 | – | – | – | – | |
| 29 | 28 | 39 | 60 | 30 | 41 | 55 | 60 | 31 | 58 | 66 | 60 | 45 | 60 | 71 | 75 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 206 | 0.4 | 0.0 | 0.4 | 575 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -5.4 | – | -5.4 | -10,415 | 0.0 | – | 0.0 | – | 2.6 | – | 2.6 | – | – | – | 2.5 | |
| 36 | 34 | 34 | 191 | 36 | 34 | 35 | 34 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | – | – | – | – | – | – | – | – | 104 | – | – | – | 104 | – | – | – | – | – | – | – | – | – | – | – | |
| -476 | 121 | 111 | 97 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.5 | 0.5 | – | – | 0.2 | 0.2 | 0.1 | 0.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 93 | -183 | -42 | -200 | -47 | -51 | -40 | -42 | -46 | -36 | -41 | -38 | -42 | 109 | -41 | -42 | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.1 | -25 | 11 | – | 11 | 22,380 | 0.1 | – | 0.1 | – | 0.1 | – | 0.1 | – | – | – | – | |
| 196 | -121 | -111 | -97 | 25 | 95 | -168 | 120 | 108 | -40 | -101 | 60 | 162 | -173 | -46 | 39 | 0.0 | 0.3 | 0.0 | -0.2 | 0.0 | 0.0 | -0.1 | -228,741 | -229 | 6.4 | – | 6.4 | 6,188 | -4.9 | 0.0 | -4.9 | 1.5 | 1.4 | – | 1.4 | – | -3.0 | 2.4 | -0.1 | |
| 99 | 57 | -67 | 104 | 72 | 146 | -128 | 158 | 150 | -0.3 | -57 | 103 | 205 | -101 | -23 | 79 | 0.0 | -0.2 | 0.0 | -0.2 | 0.0 | -0.2 | – | -0.2 | 45 | -3.0 | – | -3.0 | -6,003 | -2.5 | 0.0 | -2.5 | 1.5 | -2.0 | – | -2.0 | – | – | – | -2.6 |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.